Presentation Cell Therapy 2013

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

REGISTER for free or LOG IN to view this content

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Coronary

Presentation

Cell Therapy 2013

Up Next

Presentation CTO 2013

Introduction to the Hybrid Algorithm for CTO PCI

Presenter: Elliot Smith

February 20, 2013

More slides +

Presentation CTO 2013

2012/2013 Essential CTO Update: Rapid Review of All Essential CTO Publications and Abstracts from the Last Year

Presenter: Gerald Werner

February 20, 2013

Presentation CTO 2013

Final SYNTAX Left Main Five-Year Results: Conclusions, Speculation, and Inferences

Presenter: Patrick Serruys

February 22, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.